14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Mar 02, 2023 Sell 21 343 Silver Gabrielle Alison Common Stock
Mar 02, 2023 Sell 2 500 Silver Gabrielle Alison Stock Option (right to buy)
Mar 02, 2023 Sell 2 000 Silver Gabrielle Alison Common Stock
Mar 02, 2023 Sell 2 500 Silver Gabrielle Alison Common Stock
Mar 02, 2023 Sell 2 500 Silver Gabrielle Alison Stock Option (right to buy)
Mar 02, 2023 Sell 2 500 Silver Gabrielle Alison Stock Option (right to buy)
Mar 02, 2023 Sell 53 822 Collard Craig A Common Stock
Mar 02, 2023 Sell 5 000 Collard Craig A Common Stock
Mar 02, 2023 Sell 2 000 Collard Craig A Common Stock
Mar 02, 2023 Sell 2 500 Collard Craig A Stock Option (right to buy)
Mar 02, 2023 Sell 2 500 Collard Craig A Common Stock
Mar 02, 2023 Sell 2 500 Collard Craig A Stock Option (right to buy)
Mar 02, 2023 Sell 19 250 Ruth Matthew R. Common Stock
Mar 02, 2023 Buy 2 000 Ruth Matthew R. Common Stock
Mar 02, 2023 Sell 2 000 Ruth Matthew R. Common Stock
Mar 02, 2023 Sell 50 000 Ruth Matthew R. Stock Option (right to buy)
Mar 02, 2023 Sell 5 800 Daly Richard J Common Stock
Mar 02, 2023 Sell 2 500 Daly Richard J Stock Option (right to buy)
Mar 02, 2023 Sell 5 000 Daly Richard J Stock Option (right to buy)
Mar 02, 2023 Sell 2 500 Daly Richard J Common Stock
Mar 02, 2023 Sell 2 000 Daly Richard J Common Stock
Mar 02, 2023 Sell 2 500 Daly Richard J Stock Option (right to buy)
Mar 02, 2023 Sell 37 438 Crystal Roger Common Stock
Mar 02, 2023 Buy 6 667 Crystal Roger Common Stock
Mar 02, 2023 Sell 27 250 Crystal Roger Common Stock
Mar 02, 2023 Sell 31 250 Crystal Roger Stock Option (right to buy)
Mar 02, 2023 Sell 6 667 Crystal Roger Common Stock
Mar 02, 2023 Sell 5 100 Crystal Roger Common Stock par value $0.001
Mar 02, 2023 Sell 25 000 Crystal Roger Option
Mar 02, 2023 Sell 150 000 Crystal Roger Option
Mar 02, 2023 Sell 375 000 Crystal Roger Option
Mar 02, 2023 Sell 13 200 Crystal Roger Stock Option (right to buy)
Mar 02, 2023 Sell 7 015 Ellison Mark Jason Heath Common Stock
Mar 02, 2023 Buy 2 000 Ellison Mark Jason Heath Common Stock
Mar 02, 2023 Sell 2 000 Ellison Mark Jason Heath Common Stock
Mar 02, 2023 Sell 7 200 Ellison Mark Jason Heath Common Stock
Mar 02, 2023 Sell 8 250 Ellison Mark Jason Heath Common Stock
Mar 02, 2023 Sell 10 750 Ellison Mark Jason Heath Stock Option (right to buy)
Mar 02, 2023 Sell 9 812 Skolnick Phil Common Stock
Mar 02, 2023 Buy 2 000 Skolnick Phil Common Stock
Mar 02, 2023 Sell 2 000 Skolnick Phil Common Stock
Mar 02, 2023 Sell 40 000 Skolnick Phil Stock Option (right to buy)
Mar 02, 2023 Sell 13 200 Skolnick Phil Stock Option (right to buy)
Mar 02, 2023 Sell 8 250 Skolnick Phil Common Stock
Mar 02, 2023 Sell 10 750 Skolnick Phil Stock Option (right to buy)
Mar 02, 2023 Sell 250 000 Sinclair Michael Options
Mar 02, 2023 Sell 27 450 Sinclair Michael Common Stock
Mar 02, 2023 Sell 40 000 Sinclair Michael Common Stock, par value $0.001 per share
Mar 02, 2023 Sell 100 000 Sinclair Michael Options
Mar 02, 2023 Sell 75 000 Sinclair Michael Options
Mar 02, 2023 Sell 26 179 Macdougall Ann L. Common Stock
Mar 02, 2023 Sell 2 000 Macdougall Ann L. Common Stock
Mar 02, 2023 Sell 2 500 Macdougall Ann L. Stock Option (right to buy)
Mar 02, 2023 Sell 2 500 Macdougall Ann L. Stock Option (right to buy)
Mar 02, 2023 Sell 2 500 Macdougall Ann L. Common Stock
Mar 02, 2023 Sell 2 500 Macdougall Ann L. Stock Option (right to buy)
Mar 02, 2023 Sell 2 000 Lorianne Masuoka K. Common Stock
Mar 02, 2023 Sell 2 000 Lorianne Masuoka K. Common Stock
Mar 02, 2023 Sell 5 000 Lorianne Masuoka K. Stock Option (right to buy)
Mar 02, 2023 Sell 14 540 Gorman Brian Common Stock
Mar 02, 2023 Buy 2 000 Gorman Brian Common Stock
Mar 02, 2023 Sell 2 000 Gorman Brian Common Stock
Mar 02, 2023 Sell 36 500 Gorman Brian Stock Option (right to buy)
Mar 02, 2023 Sell 10 750 Gorman Brian Stock Option (right to buy)
Mar 02, 2023 Sell 10 375 Thomas Thomas T. Common Stock
Mar 02, 2023 Sell 2 000 Thomas Thomas T. Common Stock
Mar 02, 2023 Sell 2 500 Thomas Thomas T. Stock Option (right to buy)
Mar 02, 2023 Sell 2 500 Thomas Thomas T. Stock Option (right to buy)
Mar 02, 2023 Sell 2 500 Thomas Thomas T. Stock Option (right to buy)
Mar 02, 2023 Sell 2 500 Thomas Thomas T. Common Stock
Mar 02, 2023 Sell 22 512 O'toole David D Common Stock
Mar 02, 2023 Buy 2 000 O'toole David D Common Stock
Mar 02, 2023 Sell 2 000 O'toole David D Common Stock
Mar 02, 2023 Sell 33 000 O'toole David D Stock Option (right to buy)
Mar 02, 2023 Sell 8 250 O'toole David D Common Stock
Mar 02, 2023 Sell 10 750 O'toole David D Stock Option (right to buy)
Jan 27, 2023 Sell 1 358 Crystal Roger Common Stock
Jan 27, 2023 Sell 610 Ellison Mark Jason Heath Common Stock
Jan 27, 2023 Sell 444 Gorman Brian Common Stock
Jan 27, 2023 Sell 480 Skolnick Phil Common Stock
Jan 27, 2023 Sell 541 O'toole David D Common Stock
Jan 09, 2023 Sell 415 O'toole David D Common Stock
Jan 09, 2023 Sell 469 Ellison Mark Jason Heath Common Stock
Jan 09, 2023 Sell 369 Skolnick Phil Common Stock
Jan 09, 2023 Sell 1 183 Crystal Roger Common Stock
Jan 05, 2023 Sell 1 806 Ellison Mark Jason Heath Common Stock
Jan 05, 2023 Sell 1 600 O'toole David D Common Stock
Jan 05, 2023 Sell 1 313 Gorman Brian Common Stock
Jan 05, 2023 Sell 1 421 Skolnick Phil Common Stock
Jan 05, 2023 Sell 5 029 Crystal Roger Common Stock
Jul 20, 2022 Sell 1 084 Ruth Matthew R. Common Stock
Jul 14, 2022 Sell 779 O'toole David D Common Stock
Jul 14, 2022 Sell 627 Skolnick Phil Common Stock
Jul 14, 2022 Sell 691 Gorman Brian Common Stock
Jul 14, 2022 Sell 2 246 Crystal Roger Common Stock
Jun 27, 2022 Buy 2 000 Ellison Mark Jason Heath Common Stock
Jun 27, 2022 Buy 6 667 Crystal Roger Common Stock
Jun 27, 2022 Buy 2 000 O'toole David D Common Stock
Jun 27, 2022 Buy 2 000 Skolnick Phil Common Stock
Jun 27, 2022 Buy 2 000 Gorman Brian Common Stock
INSIDER POWER
-41.947
Last 100 transactions
Buy: 31 334 | Sell: 1 708 118 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be negative at a ratio of -41.947.

In total, the insiders bought 31 334 and sold 1 708 118 OPNT shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Opiant Pharmaceuticals Inc.

Opiant Pharmaceuticals. Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and change... OPNT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT